ArticleCPT: pharmacometrics & systems pharmacology2021

Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach.

Elena M Tosca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.